Betaxolol, a beta 1-selective antagonist, produced marked improvement in eight patients with neuroleptic-induced akathisia. No further improvement was seen with subsequent propranolol treatment. These findings, along with the results of prior studies of betaxolol and metoprolol, suggest that blockade of central beta 1-receptors may be sufficient for efficacy in akathisia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0165-1781(91)90087-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Restless legs syndrome, neuroleptic-induced akathisia, and the iron opioid dopamine link.
Sleep
March 2024
Professor of Neurology, Division of Sleep Medicine, Vanderbilt University School of Medicine, Medical Center North A-0118, Nashville, TN, USA.
Restless legs syndrome, neuroleptic-induced akathisia, and opioid-withdrawal restlessness: shared neuronal mechanisms?
Sleep
March 2024
Department of Neurology and Sleep Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Restlessness is a core symptom underlying restless legs syndrome (RLS), neuroleptic-induced akathisia, and opioid withdrawal. These three conditions also share other clinical components suggesting some overlap in their pathophysiology. Recent prospective studies demonstrate the frequent incidence of RLS-like symptoms during opioid withdrawal and supervised prescription opioid tapering.
View Article and Find Full Text PDFEfficacy of low-dose D/D partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study.
Neuropsychiatr Dis Treat
August 2019
Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University of Medicine, Shanghai, People's Republic of China.
Objective: Some lines of evidence show that D/D receptor partial agonist pramipexole may be effective in the treatment of extrapyramidal symptoms (EPS) and psychiatric symptoms of schizophrenia. Therefore, we analyzed whether a low dose of pramipexole (0.375-0.
View Article and Find Full Text PDFLower limb flexor reflex: Comparisons between drug-induced akathisia and restless legs syndrome.
Neurosci Lett
February 2017
Department of Neurology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.
Background And Objective: Akathisia is characterized by restlessness and crawling sensations similar to restless legs syndrome (RLS). Long latency flexor reflex (LLFR) which has helped to advance RLS pathophysiology has never been investigated in akathisia. Due to the clinical commonalities of akathisia and RLS, we investigated the behavior of LLFR in patients with akathisia aiming to understand pathophysiology of akathisia.
View Article and Find Full Text PDFClonidine Use in Psychiatry: Panacea or Panache.
Pharmacology
March 2017
Child and Adolescent Psychiatrist, KCMH, Shwaikh, Kuwait.
Clonidine, an alpha agonist, formally prescribed in clinical medicine as antihypertensive medication, is currently being used more frequently to address a multitude of psychiatric entities. The long-acting formulation is approved by the Food and Drug Administration for use in treating the attention-deficit/hyperactivity disorder. In addition to this only legitimate indication, it has long been used successfully for opiate detoxification, post-traumatic stress disorder and de la Tourette syndrome.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!